140 related articles for article (PubMed ID: 1383335)
1. The supportive effects of IL-7 on eosinophil progenitors from human bone marrow cells can be blocked by anti-IL-5.
Vellenga E; Esselink MT; Straaten J; Stulp BK; De Wolf JT; Brons R; Giannotti J; Smit JW; Halie MR
J Immunol; 1992 Nov; 149(9):2992-5. PubMed ID: 1383335
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
3. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
Bot FJ; van Eijk L; Schipper P; Löwenberg B
Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
[TBL] [Abstract][Full Text] [Related]
4. Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.
Warren DJ; Moore MA
J Immunol; 1988 Jan; 140(1):94-9. PubMed ID: 3257232
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
6. Influence of interleukins 3,5, and 6 on the growth of eosinophil progenitors in highly enriched human bone marrow in the absence of serum.
Lu L; Lin ZH; Shen RN; Warren DJ; Leemhuis T; Broxmeyer HE
Exp Hematol; 1990 Dec; 18(11):1180-6. PubMed ID: 1699774
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
[TBL] [Abstract][Full Text] [Related]
10. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
Migliaccio G; Migliaccio AR; Adamson JW
Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
[TBL] [Abstract][Full Text] [Related]
11. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
van de Ven C; Ishizawa L; Law P; Cairo MS
Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
[TBL] [Abstract][Full Text] [Related]
12. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Effects of rhIL-1 alpha, rhIL-1 beta, and rhIL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow.
Aoki I; Homori M; Nakahara K; Higashi K; Ishikawa K
Exp Hematol; 1995 Mar; 23(3):217-25. PubMed ID: 7533099
[TBL] [Abstract][Full Text] [Related]
15. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin 6.
Quesenberry PJ; McGrath HE; Williams ME; Robinson BE; Deacon DH; Clark S; Urdal D; McNiece IK
Exp Hematol; 1991 Jan; 19(1):35-41. PubMed ID: 1703492
[TBL] [Abstract][Full Text] [Related]
16. Effects of stem cell factor (SCF) on human marrow neutrophil, neutrophil/macrophage mixed, macrophage and eosinophil progenitor cell growth.
Ichihara M; Hotta T; Asano H; Inoue C; Murate T; Kobayashi M; Saito H
Int J Hematol; 1994 Feb; 59(2):81-9. PubMed ID: 7517201
[TBL] [Abstract][Full Text] [Related]
17. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
[TBL] [Abstract][Full Text] [Related]
18. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE
Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
20. Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks.
Moroz C; Grunspan A; Zahalka MA; Traub L; Kodman Y; Yaniv I
Exp Hematol; 2006 Feb; 34(2):159-66. PubMed ID: 16459184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
